The purpose of iVascular is to develop innovative advanced medical devices and therapies for the treatment of disorders of the cardiovascular system.

Its staff has extensive knowledge of biopolymers, coatings, drug delivery, mechanical engineering, medicine and pharmacy. They bring together recognised experience in the development of medical devices and implants.

Thanks to the know-how provided by our scientists and technicians and an appropriate investment in technology, iVascular has implemented a vertical integration project allowing it to develop, innovate and produce cardiovascular devices from basic raw materials (plastics, polymers, metals, etc.) to the final device or implant.

iVascular possesses and develops its own technologies, which have made possible the vertical integration of each and every one of the processes involved in developing a device, from the earliest design stages through to final production. In this way we guarantee the highest quality standards in all our products. iVascular has a technology center with more than 1000 m² of clean rooms (ISO 7 and ISO 8) and 250 m² of R&D laboratories equipped with the most comprehensive, advanced instrumentation in the biotechnology field.

Through its direct and indirect sales network, iVascular is present in more than 70 countries around the world, and is providing with full range of products for interventional cardiology and endovascular procedures.

For more information about  iVascular, please, visit www.ivascular.global or If you have any questions or comments, we are ready to help you out by an e-mail to info@ivascular.global

Biotechnology

Medical Devices

iVascular

iVascular's headquarters in Freiburg im Breisgau, Germany

Lluís Duocastella

Anna M. Hueto

Ralf Beck

José Luis Rodríguez Ruiz

Pol Alsius Creus

Natalia París Sotés

Jordi Llobet

Pau Llado Perez

Marta Duran

Description

People (1)

Ralf Beck

Jobs